文献速递妇科

宫内节育器对人乳头状瘤病毒获得与清除的影响

The effect of intrauterine devices on acquisition and clearance of human papillomavirus.
PubMed 文献 · Am J Obstet Gynecol · 2016-12-14

前瞻性队列研究纳入676名旧金山计划生育诊所的性活跃年轻女性,随访2000年10月至2014年6月,85人曾使用宫内节育器。调整行为混杂因素后,宫内节育器使用与HPV获得(HR 0.50,95%CI 0.20-1.23,P=.13)及清除(HR 1.44,95%CI 0.76-2.72,P=.26)均无关联。结论认为当前使用宫内节育器与HPV感染获得或持续无关,在HPV感染女性中使用是安全的。

要点

  • 宫内节育器使用与HPV获得无关联(HR 0.50,95%CI 0.20-1.23,P=.13)。
  • 宫内节育器使用与HPV清除无关联(HR 1.44,95%CI 0.76-2.72,P=.26)。
  • 在HPV感染及有感染风险的女性中,宫内节育器使用是安全的。

核心结论

  • 当前使用宫内节育器与HPV感染的获得或持续无关。
  • 在HPV感染及有HPV感染风险的女性中,宫内节育器使用是安全的。
  • 宫内节育器可能通过抑制HPV感染女性宫颈癌前病变的发生或促进已建立癌前病变的清除,在宫颈癌自然史的更下游环节发挥作用。

研究设计与样本

  • 前瞻性队列研究,2000年10月至2014年6月从加州旧金山计划生育诊所纳入676名性活跃年轻女性。
  • 使用Cox比例风险模型分析,包含宫内节育器使用的时间变化指标,并调整固定和时依预测变量。

主要发现

  • 随访期间共85名女性曾使用宫内节育器。
  • 在14,513次研究访视中,女性报告使用宫内节育器505次。
  • 调整潜在行为混杂因素后,宫内节育器使用与HPV获得无关联(HR 0.50,95%CI 0.20-1.23,P=.13)。
  • 调整潜在行为混杂因素后,宫内节育器使用与HPV感染清除无关联(HR 1.44,95%CI 0.76-2.72,P=.26)。

临床怎么用

  • 作者认为,当前使用宫内节育器与HPV感染的获得或持续无关,在HPV感染及有感染风险的女性中使用是安全的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have shown a decrease in cervical cancer associated with intrauterine device use. It has been hypothesized that intrauterine device use may alter the natural history of human papillomavirus infections, preempting development of precancerous lesions of the cervix and cervical cancer, but the effect of intrauterine devices on the natural history of human papillomavirus infection and subsequent development of cervical cancer is poorly understood. OBJECTIVE: The purpose of this study was to evaluate the association between intrauterine device use and cervical high-risk human papillomavirus acquisition and clearance. STUDY DESIGN: This is a prospective cohort study conducted from October 2000 through June 2014 among 676 sexually active young women and girls enrolled from family planning clinics in San Francisco, CA. Data were analyzed using a Cox proportional hazards model, including time-varying indicators of intrauterine device use, and adjusting for fixed and time-dependent predictor variables. RESULTS: A total of 85 women used an intrauterine device at some time during follow-up. Among 14,513 study visits, women reported intrauterine device use at 505 visits. After adjusting for potential behavioral confounders, there was no association between intrauterine device use and human papillomavirus acquisition (hazard ratio, 0.50; 95% confidence interval, 0.20-1.23; P = .13) or clearance of human papillomavirus infection (hazard ratio, 1.44; 95% confidence interval, 0.76-2.72; P = .26). CONCLUSION: Current intrauterine device use is not associated with acquisition or persistence of human papillomavirus infection. Intrauterine device use is safe among women and girls with human papillomavirus infections and at risk for human papillomavirus acquisition. Intrauterine device use may play a role further downstream in the natural history of cervical cancer by inhibiting the development of precancerous lesions of the cervix in human papillomavirus-infected women, or enhancing clearance of established precancerous lesions.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Averbach SH, Ma Y, Smith-McCune K, et al. The effect of intrauterine devices on acquisition and clearance of human papillomavirus. Am J Obstet Gynecol. 2016. PMID: 27986460. doi:10.1016/j.ajog.2016.11.1053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。